business / news
Anodyne Nanotech Raises $12.6M Series A to Take a Once-Weekly GLP-1 Patch into Human Trials
The Boston biotech wants to replace the GLP-1 injection with a room-temperature patch — no needles, no cold storage. Its Series A funds the first clinical test of that idea.
Editorial Team · 3 min read
lifespan / news
Life Biosciences Doses First Patient in Landmark Trial of Cellular-Reprogramming Therapy for Vision Loss
ER-100 is one of the first attempts to take partial epigenetic reprogramming — resetting cells to a "younger" state — from the lab into a human trial. The first patient has now been dosed.
Editorial Team · 4 min read